Clinical Trial Summary (S2409)
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer (PRISM Trial)
What is the purpose of this clinical trial?
The summary for the S2409 PRISM trial is being updated. A new version will be posted here shortly.
Where can I find more information about this trial?
- Talk with your health care provider
- Call the National Cancer Institute at 1-800-4-CANCER
- Go to www.ClinicalTrials.gov and search the national clinical trial number: NCT06769126
- For a list of trial locations, visit swog.org/NCI-S2409
Key Information
Information your doctor or trial navigator may need to help you.
Protocol Number
S2409
NCT Number
NCT06769126
Full Trial Title
PRISM: Precision in SCLC via a Multicohort Study: Randomized Phase II Studies Evaluating Maintenance Durvalumab with or without Biomarker-Directed Therapy for Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Trial Sponsors
SWOG Cancer Research Network
Publication Date